HNSCC

JERUSALEM, Israel – May 5, 2026 Alpha Tau Medical Ltd. has announced that new clinical data evaluating Alpha DaRT®...

SAN MATEO, Calif., April 19, 2026 EpiBiologics has announced that the first patient has been dosed in its global...

RARITAN, N.J., Feb. 19, 2026 — Johnson & Johnson announced new Phase 1b/2 clinical data demonstrating that subcutaneous RYBREVANT...

BOSTON, Mass., Feb. 20, 2026 — New clinical findings presented at a major oncology symposium demonstrate that ficerafusp alfa...

Kenilworth, N.J., October 29, 2025— Merck & Co., Inc. (NYSE: MRK), known as MSD outside the U.S. and Canada,...